The Prescription Drug User Fee Act date refers to the deadline set by the FDA for reviewing a NDA or Biologics License Application.
Glaucoma prevalence appears higher than prior research has estimated, with approximately 4.22 million US adults affected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback